Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Residual homing of alpha 4 beta 7-expressing beta 1(+)PI16(+) regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab (2021) Becker E, Dedden M, Gall C, Wiendl M, Ekici AB, Schulz-Kuhnt A, Schweda A, et al. Journal article Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy (2021) Bojarski C, Waldner M, Rath T, Schürmann S, Neurath M, Atreya R, Siegmund B Journal article, Review article The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases (2021) Anchang CG, Xu C, Raimondo MG, Atreya R, Maier A, Schett G, Zaburdaev V, et al. Journal article, Review article PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES ARE OVERREPRESENTED IN LOW-FREQUENCY VIRAL SYMPTOM CLUSTERS (2021) Tascilar K, Simon D, Krönke G, Kleyer A, Ramming A, Atreya R, Tenbusch M, et al. Conference contribution Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy (2021) Berte R, Mazza S, Stefanucci MR, Noviello D, Costa S, Ciafardini C, Mileti E, et al. Journal article Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients? (2021) Atreya R, Neurath M Journal article Real World Evidence on the effectiveness of ustekinumab in Crohn's Disease: Induction phase results from the prospective, observational RUN-CD Study (2021) Bokemeyer B, Plachta-Danielzik S, Di Giuseppe R, Mohl W, Teich N, Hoffstadt M, Schweitzer A, et al. Conference contribution Role of the IL23/IL17 Pathway in Crohn’s Disease (2021) Schmitt H, Neurath M, Atreya R Journal article, Review article CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental Colitis (2021) Kang L, Schmalzl A, Leupold T, Gonzalez-Acera M, Atreya R, Neurath M, Becker C, Wirtz S Journal article The JAK1/3 Inhibitor to Tofacitinib Suppresses T Cell Homing and Activation in Chronic Intestinal Inflammation (2021) Gerlach K, Lechner K, Popp V, Offensperger L, Zundler S, Wiendl M, Becker E, et al. Journal article